Who are UroGen Pharma Ltd.'s main suppliers?

UroGen Pharma Ltd. (URGN) key suppliers include: Agenus Inc., Aura Biosciences, Inc., Lite Strategy, Inc.. View the full supplier network at chainsifter.com/chain/URGN.

Who are UroGen Pharma Ltd.'s major customers?

UroGen Pharma Ltd. (URGN) key customers include: JELMYTO, ZUSDURI, ISOTOPIA-MOLECULAR-IMAGING-LTD, JPMorgan Chase & Co., JPMorgan Chase & Co. and 2 more. View the full customer network at chainsifter.com/chain/URGN.

What sector is UroGen Pharma Ltd. in?

UroGen Pharma Ltd. (URGN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

UroGen Pharma Ltd. Suppliers, Customers & Supply Chain (URGN)

3Suppliers

7Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

UroGen Pharma Ltd. (URGN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

14Total relationships

2Distinct source URLs

7High confidence

0.795Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

UroGen Pharma Ltd. Suppliers

Ticker	Name	Confidence	Evidence
AGEN	Agenus Inc.	72%	Reciprocal relationship from AGEN graph: Reciprocal relationship from URGN graph: Reciprocal relationship from AGEN graph: Reciprocal relationship from URGN graph: Reciprocal relationship from AGEN g…
AURA	Aura Biosciences, Inc.	72%	Reciprocal relationship from AURA graph: Reciprocal relationship from URGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from URGN graph: Reciprocal relationship from AURA g…
LITS	Lite Strategy, Inc.	72%	Reciprocal relationship from LITS graph: Reciprocal relationship from URGN graph: Reciprocal relationship from LITS graph: Reciprocal relationship from URGN graph: Reciprocal relationship from LITS g…

UroGen Pharma Ltd. Customers

Ticker	Name	Confidence	Evidence
JELMYTO	JELMYTO	92%	All product sales of Jelmyto and Zusduri are recognized through the Company's arrangements with two customers as defined by ASC 606, both of which are third-party national specialty distributors.
ZUSDURI	ZUSDURI	92%	All product sales of Jelmyto and Zusduri are recognized through the Company's arrangements with two customers as defined by ASC 606, both of which are third-party national specialty distributors.
ISOTOPIA-MOLECULAR-IMAGING-LTD	ISOTOPIA-MOLECULAR-IMAGING-LTD	85%	political, economic and military conditions in Israel.* Our research and development facility is located in Ra’anana, Israel, and certain of our key vendors and suppliers, including Isotopia Molecula…
JPM-PD	JPMorgan Chase & Co.	72%	Reciprocal relationship from JPM-PD graph: Reciprocal relationship from URGN graph: Reciprocal relationship from JPM-PD graph: Reciprocal relationship from URGN graph: Reciprocal relationship from JP…
JPM-PD	JPMorgan Chase & Co.	72%	political, economic and military conditions in Israel.* Our research and development facility is located in Ra’anana, Israel, and certain of our key vendors and suppliers, including Isotopia Molecula…
ALLERGAN-PHARMACEUTICALS-LIMITED	ALLERGAN-PHARMACEUTICALS-LIMITED	62%	hion to support the initiation of clinical trials; • obtaining regulatory approval to commence clinical trials in any jurisdiction, including the submission and acceptance of INDs; • contracting with…
ICONOVIR-BIO-INC	ICONOVIR-BIO-INC	62%	eased aspartate aminotransferase, increased alanine aminotransferase, increased eosinophils, decreased lymphocytes, urinary tract infection, decreased neutrophils, and hematuria. Serious adverse reac…

UroGen Pharma Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
URGN-DEBT-13241	Warrants outstanding: 18641000	90%	xbrl warrant detail from xbrl 2024-12-31.
URGN-DEBT	Debt stack $188.7M	90%	Market cache reports total debt of $188.7M.
URGN-DEBT-13242	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

UroGen Pharma Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for UroGen Pharma Ltd..

UroGen Pharma Ltd. Ownership

Holder	Name	Confidence	Evidence
URGN-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 174 tracked holders.

UroGen Pharma Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
AURA	Aura Biosciences, Inc.	100.00	1	['supplier']
AGEN	Agenus Inc.	100.00	1	['supplier']
JPM-PD	JPMorgan Chase & Co.	100.00	1	['customer']
CGON	CG Oncology, Inc.	100.00	2
LITS	Lite Strategy, Inc.	100.00	1	['supplier']
JNJ	Johnson & Johnson	100.00	2
CINF	Cincinnati Financial Corporation	50.00	2
CNTA	Centessa Pharmaceuticals plc	50.00	2
ORANY	ORANGE	50.00	2
ANEB	Anebulo Pharmaceuticals, Inc.	50.00	2
ACGL	Arch Capital Group Ltd.	50.00	2
CB	Chubb Limited	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
GILD	Gilead Sciences, Inc.	50.00	2
ENGN	enGene Therapeutics Inc.	50.00	2
JPM-PM	JPMORGAN CHASE & CO	50.00	2
IDAI	T Stamp Inc.	50.00	2
HOLX	Hologic, Inc.	50.00	2
JPM	JPMorgan Chase & Co.	50.00	2

UroGen Pharma Ltd. Supply Chain